Moramide intermediate explained

Moramide intermediate (β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.

In the United States, moramide intermediate is designated as a Schedule II controlled substance,^[1] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.^[2]

In Australia, moramide intermediate is listed as a Schedule 9 (Prohibited Substance)^[3]

See also

• Moramide
• Methadone intermediate
• Pethidine intermediate A
• Pethidine intermediate B (norpethidine)
• Pethidine intermediate C (pethidinic acid)

Notes and References

1. http://www.deadiversion.usdoj.gov/schedules/orangebook/d_cs_drugcode.pdf Controlled Substances - by DEA Drug Code Number
2. Web site: DEA Diversion Control Division.
3. Web site: Therapeutic Goods (Poisons Standard—February 2024) Instrument 2024 . Federal Register of Legislation . 18 June 2024 . 23 January 2024.